AcelRx Pharmaceuticals, Inc. (ACRX)
NASDAQ: ACRX · IEX Real-Time Price · USD
0.735
-0.084 (-10.26%)
At close: Dec 29, 2023, 4:00 PM
0.750
+0.015 (2.04%)
After-hours: Dec 29, 2023, 7:58 PM EST
AcelRx Pharmaceuticals Stock Forecast
ACRX's stock price has decreased by -65.49% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 2 stock analysts, the average 12-month stock price forecast for ACRX stock stock is $4.63, which predicts an increase of 529.93%. The lowest target is $4.25 and the highest is $5.00. On average, analysts rate ACRX stock stock as a strong buy.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for ACRX stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '23 | Aug '23 | Sep '23 | Oct '23 | Nov '23 | Dec '23 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 1 | 1 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +580.27% | Dec 7, 2023 |
| Alliance Global Partners | Alliance Global Partners | Strong Buy Initiates $4 | Strong Buy | Initiates | $4 | +478.23% | Oct 2, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $8 → $5 | Strong Buy | Maintains | $8 → $5 | +580.27% | Sep 25, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold → Strong Buy Upgrades $8 | Hold → Strong Buy | Upgrades | $8 | +988.44% | Aug 18, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Mar 14, 2022 |
Financial Forecast
Revenue This Year
520.71K
from 1.77M
Decreased by -70.60%
Revenue Next Year
1.39M
from 520.71K
Increased by 167.33%
EPS This Year
-1.20
from 5.72
EPS Next Year
-0.80
from -1.20
Revenue Forecast
| Revenue | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| High | 683,550 | 1.4M | 4.3M | 14.9M | 29.8M | 62.7M |
| Avg | 520,710 | 1.4M | 2.6M | 12.6M | 29.0M | 60.9M |
| Low | 362,600 | 1.3M | 939,820 | 10.2M | 27.9M | 58.5M |
Revenue Growth
| Revenue Growth | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| High | -61.4% | 175.2% | 205.3% | 485.2% | 137.2% | 116.2% |
| Avg | -70.6% | 167.3% | 83.5% | 392.5% | 130.5% | 110.0% |
| Low | -79.5% | 157.0% | -32.5% | 300.2% | 121.4% | 101.8% |
EPS Forecast
| EPS | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| High | -1.24 | -0.82 | -0.74 | -0.45 | 0.08 | 0.96 |
| Avg | -1.20 | -0.80 | -0.78 | -0.58 | 0.08 | 0.93 |
| Low | -1.16 | -0.76 | -0.80 | -0.69 | 0.08 | 0.89 |
EPS Growth
| EPS Growth | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| High | - | - | - | - | - | 1,071.0% |
| Avg | - | - | - | - | - | 1,037.5% |
| Low | - | - | - | - | - | 992.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.